Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 41.21B | 41.37B | 41.23B | 51.03B | 38.96B | 35.44B |
Gross Profit | 5.73B | 6.21B | 4.73B | 9.45B | 6.73B | 6.77B |
EBITDA | 1.12B | 2.01B | 502.00M | 4.81B | 2.44B | 2.51B |
Net Income | 70.00M | 350.00M | -630.00M | 2.17B | 1.02B | 829.00M |
Balance Sheet | ||||||
Total Assets | 49.24B | 50.09B | 48.65B | 49.39B | 43.07B | 40.53B |
Cash, Cash Equivalents and Short-Term Investments | 4.13B | 2.10B | 2.33B | 1.90B | 2.00B | 2.81B |
Total Debt | 14.67B | 14.85B | 12.40B | 10.12B | 7.21B | 7.31B |
Total Liabilities | 25.84B | 26.23B | 25.09B | 24.56B | 20.05B | 18.23B |
Stockholders Equity | 23.35B | 23.82B | 23.50B | 24.78B | 22.97B | 22.25B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | -1.76B | -944.00M | -2.44B | -896.00M | 630.00M |
Operating Cash Flow | 0.00 | 152.00M | 1.52B | -1.21B | 341.00M | 2.65B |
Investing Cash Flow | 0.00 | -2.48B | -2.21B | -1.24B | -529.00M | -1.94B |
Financing Cash Flow | 0.00 | 2.11B | 1.12B | 2.35B | -624.00M | -1.29B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | ¥35.64B | 9.07 | 2.87% | 3.74% | 23.59% | ||
75 Outperform | ¥18.03B | 12.34 | 2.01% | 9.14% | 6.18% | ||
75 Outperform | ¥23.23B | 9.66 | 2.81% | 10.02% | 56.26% | ||
69 Neutral | ¥99.46B | 9.08 | 367.06% | 10.07% | -38.38% | ||
64 Neutral | ¥8.57B | 24.39 | 2.09% | 0.33% | ― | ||
62 Neutral | $10.21B | 10.03 | -0.16% | 2.84% | 2.22% | -32.59% |